Optometrists back Aussie-developed AI system

Australian optometrists are reporting positive results with a homegrown clinical decision support tool that uses artificial intelligence (AI) to analyse retinal images for features of the major blinding eye diseases. Read more

Biotech tax cut and trachoma feature in Federal Budget

A tax cut for medical and biotech companies generating income from new patents developed in Australia, a further expansion of a traineeship wage subsidy and $19.1 million towards trachoma elimination are the main 2021-22 Federal Budget announcements affecting the ophthalmic sector. Read more

Catering for a new optometric era

Trends already shaping modern optometry were set on an even steeper trajectory with the advent of COVID-19. MS HILKE FITZSIMONS explains why Zeiss Vision Care’s future-focused products are well-positioned to support optometry during its next evolution.

Read more